Short-term prophylaxis with ciprofloxacin in extended 16-core prostate biopsy

Short-term prophylaxis with ciprofloxacin in extended 16-core prostate biopsy

Objective To evaluate the safety, efficacy and possible complications of 16-core transrectal prostate biopsies using two doses of ciprofloxacin for prophylaxis of infectious complications. Materials and Methods Sixteen-core prostate biopsies were performed on a number of patients with different sign...

Full description

Bibliographic Details
Main Authors:	Renato Caretta Chambó, Fábio Hissachi Tsuji, Hamilton Akihissa Yamamoto, Carlos Márcio Nóbrega de Jesus
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Urologia 2015-02-01
Series:	International Brazilian Journal of Urology
Subjects:	prostate prostatic neoplasms biopsy complications
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382015000100046&lng=en&tlng=en

Similar Items

Acute prostatitis after prostate biopsy under ciprofloxacin prophylaxis with or without ornidazole and pre-biopsy enema: analysis of 3.479 prostate biopsy cases
by: Muhsin Balaban, et al.
Published: (2019-01-01)

Comparison of a combined regimen of fosfomycin and ciprofloxacin with ciprofloxacin alone as antimicrobial prophylaxis for transrectal prostate biopsy in the era of high fluoroquinolone-resistant rectal flora
by: Do Gyeong Lim, et al.
Published: (2021-09-01)

Single-Dose Versus Multiple-Dose Ciprofloxacin Plus Metronidazole Prophylaxis in Transrectal Ultrasound-Guided Biopsy of the Prostate: a Randomized Controlled Trial
by: Zhoobin Heidari Bateni, et al.
Published: (2014-09-01)

Detection rate of prostate cancer following 12-core extended biopsy in a Semi-urban Nigerian Tertiary Hospital
by: Friday Emeakpor Ogbetere, et al.
Published: (2021-01-01)

Repeated biopsy in the detection of prostate cancer: When and how many cores
by: Vincenzo Scattoni, et al.
Published: (2014-12-01)

Comparison of amikacin with fosfomycin as an add-on to ciprofloxacin for antibiotic prophylaxis in transrectal prostate biopsy: A single-center retrospective study
by: Seong Hyeon Yu, et al.
Published: (2022-11-01)

Combined antibiotic prophylaxis of infectious complications of prostate biopsy
by: N. A. Grigoryev, et al.
Published: (2021-09-01)

Fusion Biopsy, not Cognitive, Is the New Gold Standard
by: Alessandro Marquis, et al.
Published: (2023-03-01)

Fusion Biopsy, not Cognitive, Is the New Gold Standard
by: Alessandro Marquis, et al.
Published: (2023-03-01)

Comparing infective complications from transrectal ultrasound guided prostate biopsy following transition to single dose oral ciprofloxacin prophylaxis
by: Matthew Farag, et al.
Published: (2019-01-01)

Comparison of the Efficacy of Fosfomycin Trometamol and Ciprofloxacin in Transrectal Ultrasound-Assisted Prostate Biopsy Prophylaxis: Clinical Results of A Tertiary Referral Center
by: Mehmet Hamza Guktekin, et al.
Published: (2023-06-01)

Is It Effective to Perform Two More Prostate Biopsies According to Prostate-Specific Antigen Level and Prostate Volume in Detecting Prostate Cancer? Prospective Study of 10-Core and 12-Core Prostate Biopsy
by: Byung Il Yoon, et al.
Published: (2012-05-01)

Fosfomycin in antibiotic prophylaxis of infectious complications after biopsy of the prostate
by: N. A. Grigoriev, et al.
Published: (2022-04-01)

Routine systematic prostate biopsies not replaced by magnetic resonance imaging-targeted biopsy
by: David Gómez-Ortiz, et al.
Published: (2022-10-01)

Morbidity following transperineal prostate biopsy: Our experience in 8.500 men
by: Pietro Pepe, et al.
Published: (2022-06-01)

Ten-core versus 16-core transrectal ultrasonography guided prostate biopsy for detection of prostatic carcinoma: a prospective comparative study in Indian population
by: V. Surya Prakash, et al.
Published: (2013-12-01)

Can we improve the detection rate of prostate cancer using standard 12‐core TRUS‐guided prostate biopsy? Focused on the location of prostate biopsy
by: Sangjun Yoo, et al.
Published: (2020-06-01)

The Severity of Pain in Prostate Biopsy Depends on the Biopsy Sector
by: Grzegorz Rempega, et al.
Published: (2023-02-01)

Is antibiotic prophylaxis still mandatory for transperineal prostate biopsy? Results of a comparative study
by: Giacomo M. Pirola, et al.
Published: (2022-03-01)

COMPARATIVE EVALUATION OF CURRENT METHODS OF ANESTHESIA IN PERFORMANCE OF TRANSRECTAL PROSTATE BIOPSY
by: M. E. Topuzov, et al.
Published: (2015-10-01)

Clinical Value of Core Lenght in Saturation Prostate Biopsy
by: Cem Yücel, et al.
Published: (2018-06-01)

Second to fourth digit ratio: its relationship with core cancer volume and Gleason score in prostate biopsy
by: Jin Kyu Oh, et al.
Published: (2012-10-01)

How many cores should be taken from each region of interest when performing a targeted transrectal prostate biopsy?
by: Serhat Cetin, et al.
Published: (2023-06-01)

Rebiopsy rate after transperineal or transrectal prostate biopsy
by: Jose L. Marenco Jimenez, et al.
Published: (2021-06-01)

Indications for a second prostate biopsy in patients suspected with prostate cancer after an initial negative prostate biopsy
by: Kwang Suk Lee, et al.
Published: (2017-03-01)

“Targeted” prophylaxis: Impact of rectal swab culture-directed prophylaxis on infectious complications after transrectal ultrasound-guided prostate biopsy
by: Prabhjot Singh, et al.
Published: (2017-09-01)

The feasibility of distance to the tumor of biopsy cores to estimate the extracapsular extension
by: Chang Lim Hyun, et al.
Published: (2023-12-01)

A review of transrectal ultrasound guided prostate biopsies: Is there still a role for finger guided prostate biopsies?
by: K.S. Jehle, et al.
Published: (2015-03-01)

What is the ideal number of biopsy cores per lesion in targeted prostate biopsy?
by: Gokhan Sonmez, et al.
Published: (2020-09-01)

Detection rate for significant cancer at confirmatory biopsy in men enrolled in Active Surveillance protocol: 20 cores vs 30 cores vs MRI/TRUS fusion prostate biopsy
by: Pietro Pepe, et al.
Published: (2016-12-01)

Percentage of free prostate-specific antigen (PSA) is a useful method in deciding to perform prostate biopsy with higher core numbers in patients with low PSA cut-off values
by: Hasan Yilmaz, et al.
Published: (2015-06-01)

External validation of prostate health index-based nomogram for predicting prostate cancer at extended biopsy
by: Stojadinović Milorad M., et al.
Published: (2020-01-01)

Anterior prostate biopsy at initial and repeat evaluation: is it useful to detect significant prostate cancer?
by: Pietro Pepe, et al.
Published: (2015-10-01)

Safety of 12 core transrectal ultrasound guided prostate biopsy in patients on aspirin
by: Pawan Vasudeva, et al.
Published: (2015-12-01)

Prostate cancer detection at rebiopsy after an initial benign diagnosis: results using sextant extended prostate biopsy
by: Katia Ramos Moreira Leite, et al.
Published: (2008-01-01)

Antibiotic prophylaxis for transrectal prostate biopsy: A comparison of one-day and five-day regimen
by: J O Agbugui, et al.
Published: (2014-01-01)

Prophylactic role of ciprofloxacin and ceftriaxone in prostate biopsy-related infection: randomized comparative study of bacterial spectrum and antibiotic sensitivities
by: Chinonso Odo, et al.
Published: (2021-12-01)

Safety of ultrasound-guided transrectal extended prostate biopsy in patients receiving low-dose aspirin
by: Ioannis Kariotis, et al.
Published: (2010-06-01)

Nonspecific Presentation of a Multiloculated Prostatic Abscess After Transurethral Prostatic Biopsy for Elevated Prostate-specific Antigen Level
by: Nilay M. Gandhi, et al.
Published: (2014-11-01)

Continued administration of antithrombotic agents during transperineal prostate biopsy
by: Toko Asano, et al.
Published: (2015-02-01)